Giovanni Carulli, MD
Division of Hematology and Flow Cytometry Section, Department of Oncology, Transplants and New Technologies in Medicine, University of Pisa, Pisa, Italy

Alessandra Stacchini
Flow Cytometry Unit, Laboratory of Pathology, San Giovanni Battista Hospital, Torino, Italy

Alessandra Marini, MD
Laboratory of Clinical Pathology, Versilia Hospital, Lido di Camaiore, Italy

Maria Matilde Ciriello, MD
Laboratory of Clinical Pathology, SS Antonio and Biagio Hospital, Alessandria, Italy

Alessandra Zucca, MD
Division of Hematology and Flow Cytometry Section, Department of Oncology, Transplants and New Technologies in Medicine, University of Pisa, Pisa, Italy

Elisa Cannizzo, MD
Division of Hematology and Flow Cytometry Section, Department of Oncology, Transplants and New Technologies in Medicine, University of Pisa, Pisa, Italy

Sabrina Aliberti, MSc
Flow Cytometry Unit, Laboratory of Pathology, San Giovanni Battista Hospital, Torino, Italy

Anna Demurtas, MSc
Flow Cytometry Unit, Laboratory of Pathology, San Giovanni Battista Hospital, Torino, Italy

Domenico Novero, MD
Flow Cytometry Unit, Laboratory of Pathology, San Giovanni Battista Hospital, Torino, Italy

Lara Calcagno, MSc
Laboratory of Clinical Pathology, SS Antonio and Biagio Hospital, Alessandria, Italy

Tiziana Callegari, MSc
Laboratory of Clinical Pathology, SS Antonio and Biagio Hospital, Alessandria, Italy

Mario Petrini, MD
Division of Hematology and Flow Cytometry Section, Department of Oncology, Transplants and New Technologies in Medicine, University of Pisa, Pisa, Italy

Keywords: CD8; Flow cytometry; Non-Hodgkin lymphoma; B-cell chronic lymphocytic leukemia

Upon completion of this activity, you will be able to:

• list types of B-cell lymphoma in which aberrant expression of T-cell markers may occur.
• list T-cell markers that should be included in flow cytometric analysis of B-cell lymphomas.
• discuss the immunophenotyping of B-cell lymphomas.